Clinical Trial: A 6-week safety & efficacy study of combination intraocular pressure-lowering therapy in patients with open-angle glaucoma or ocular hypertension


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

A 6-week safety & efficacy study of combination intraocular pressure-lowering therapy in patients with open-angle glaucoma or ocular hypertension

This study is currently recruiting patients.

Sponsored by:	Alcon Research
Information provided by:	Alcon Research

Purpose

To compare the intraocular pressure(IOP)-lowering efficacy of morning or evening instillations of a combination IOP-lowering therapy in patients with open-angle glaucoma or ocular hypertension.

Condition	Treatment or Intervention	Phase
Glaucoma, Open-Angle Ocular Hypertension	Drug: Combination IOP Lowering Therapy	Phase II

MedlinePlus related topics: Eye Diseases; Glaucoma

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study

Official Title: A 6-week safety and efficacy study of combination IOP-lowering therapy in patients with open-angle glaucoma or ocular hypertension.

Eligibility

Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both

Criteria

Adult patients of any race and either sex with open angle glaucoma or ocular hypertension.

Location and Contact Information

Alcon Clinical +1-817-568-6747 IntlDev@alconlabs.com

Europe, ; Recruiting

More Information

Study ID Numbers: C-02-03
Record last reviewed: January 2003
Record first received: January 3, 2003
ClinicalTrials.gov Identifier: NCT00051194
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2004-10-22

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services